These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Each of the following statements about the newer medications for schizophrenia, risperidone (risperidol) and clozapine (clozaril), is true, except: Patients receiving risperidone are at risk for agranulocytosis. Can Fam Physician; 1995 Oct; 41():1678, 1680. PubMed ID: 8829578 [No Abstract] [Full Text] [Related]
7. Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis. Oh PI; Iskedjian M; Addis A; Lanctôt K; Einarson TR Can J Clin Pharmacol; 2001; 8(4):199-206. PubMed ID: 11743592 [TBL] [Abstract][Full Text] [Related]
8. Predictors of Clozapine Funding in Southwestern Ontario. Pallaveshi L; Mak M; Rudnick A Psychiatr Serv; 2016 Jan; 67(1):143-4. PubMed ID: 26725498 [No Abstract] [Full Text] [Related]
9. Refractory schizophrenia: what works pharmacologically? Sousa S J Psychosoc Nurs Ment Health Serv; 1999 Feb; 37(2):19-23. PubMed ID: 10023603 [TBL] [Abstract][Full Text] [Related]
10. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Rosenheck R; Cramer J; Xu W; Thomas J; Henderson W; Frisman L; Fye C; Charney D N Engl J Med; 1997 Sep; 337(12):809-15. PubMed ID: 9295240 [TBL] [Abstract][Full Text] [Related]
11. New vs. old antipsychotics: the Texas experience. Reid WH J Clin Psychiatry; 1999; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167 [TBL] [Abstract][Full Text] [Related]
12. Unbuckling the "chemical straitjacket": the legal significance of recent advances in the pharmacological treatment of psychosis. Mossman D San Diego Law Rev; 2002; 39(4):1033-164. PubMed ID: 15212045 [No Abstract] [Full Text] [Related]
13. Underprescribing of clozapine and unexplained variation in use across hospitals and regions in the Canadian province of Québec. Latimer E; Wynant W; Clark R; Malla A; Moodie E; Tamblyn R; Naidu A Clin Schizophr Relat Psychoses; 2013 Apr; 7(1):33-41. PubMed ID: 23367500 [TBL] [Abstract][Full Text] [Related]
15. [Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics]. Geronimi-Ferret D; Lesay M; Barges-Bertocchio MH; Cornet-Bonnefont M; Robert H Encephale; 1997 Sep; 23 Spec No 4():24-31. PubMed ID: 9417402 [TBL] [Abstract][Full Text] [Related]
16. Should clozapine continue to be restricted to third-line status for schizophrenia?: a decision-analytic model. Wang PS; Ganz DA; Benner JS; Glynn RJ; Avorn J J Ment Health Policy Econ; 2004 Jun; 7(2):77-85. PubMed ID: 15208468 [TBL] [Abstract][Full Text] [Related]
17. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center]. Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P Encephale; 1998; 24(4):365-77. PubMed ID: 9809242 [TBL] [Abstract][Full Text] [Related]
18. Cost of the Illness of Treatment-Resistant Schizophrenia: A Mirror Image Study Comparing Clozapine With Other Antipsychotics. Verma M; Grover S; Chakrabarti S J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):36-44. PubMed ID: 33347021 [TBL] [Abstract][Full Text] [Related]
19. Clozapine alone versus clozapine and risperidone for refractory schizophrenia. Grass G; Hellmich M; Leweke FM N Engl J Med; 2006 Apr; 354(17):1846-8; author reply 1846-8. PubMed ID: 16641404 [No Abstract] [Full Text] [Related]
20. [Clozapine in the treatment of schizophrenia]. Kane JM Encephale; 1996 Dec; 22 Spec No 6():7-11. PubMed ID: 9102320 [No Abstract] [Full Text] [Related] [Next] [New Search]